Can I have IV ketamine if I have sleep apnea?

In most cases yes. Consensus guidelines treat obstructive sleep apnea as a reason for screening and closer monitoring rather than a contraindication, and ketamine is generally considered a favorable choice compared with opioids or propofol because it tends to preserve respiratory drive and airway tone. We will want to know whether yours is diagnosed and whether it is being treated.

Is ketamine safer for my airway than other sedatives?

The evidence points that way. Research shows ketamine tends to maintain or increase upper airway dilator muscle activity and preserve protective reflexes, while opioids and propofol reliably reduce airway tone and depress respiratory drive. Imaging studies found that adding ketamine to propofol reduced airway narrowing compared with propofol alone. That is a meaningful difference, though it does not eliminate the need for monitoring.

Should I bring my CPAP machine to the infusion?

Generally not necessary. A ketamine infusion is not sleep, and you will be drowsy and dissociated rather than asleep, under continuous monitoring throughout. Do tell us that you use CPAP and how consistently, because that tells us how well controlled your apnea is and shapes how closely we watch you.

How is monitoring different for patients with sleep apnea?

The core monitoring is the same for everyone: continuous pulse oximetry, cycled blood pressure, heart rate, and clinical assessment of breathing. For patients at elevated respiratory risk, professional guidance recommends adding continuous end-tidal carbon dioxide monitoring, and positioning matters more. Marla's background is anesthesia and airway management, which is the relevant expertise here.

What if I think I have sleep apnea but have never been tested?

Tell us at consultation. Undiagnosed sleep apnea is common and produces symptoms that closely resemble depression, including fatigue, low mood, poor concentration and low motivation. Depending on what you describe, we may recommend a sleep study before or alongside ketamine therapy. Sometimes that turns out to be the more useful intervention.

Ketamine and Sleep Apnea: Why We Ask Whether You Snore

Why a mental health clinic asks about snoring

Somewhere in the intake paperwork we ask whether you snore, whether anyone has witnessed you stop breathing during sleep, whether you wake unrefreshed. Patients coming in for depression sometimes find this a strange detour.

There are two reasons. The first is that ketamine is a sedating medication given in a room where you will be reclined and drowsy, and obstructive sleep apnea is the single most common condition that makes sedation riskier. The second is that untreated sleep apnea is a well-recognized driver of depressive symptoms, so the answer occasionally reframes the whole picture.

What makes sedation riskier in sleep apnea

Obstructive sleep apnea is a mechanical problem. During sleep the muscles holding the upper airway open relax, soft tissue collapses inward, and breathing stops until the brain briefly rouses and the airway reopens. In moderate to severe cases this can repeat dozens of times an hour.

Sedatives make it worse by suppressing the muscle tone that keeps the airway open and, for many drug classes, by blunting the brain's response to rising carbon dioxide — the very alarm that ends an apneic episode. That is why anesthesiologists treat sleep apnea as a meaningful perioperative risk factor, and why it belongs on any screening form for a sedating infusion.

Ketamine behaves differently from most sedatives

This is where ketamine's unusual pharmacology works in your favor. Unlike most drugs used for sedation, ketamine tends to preserve, and in some measurements increase, respiratory drive.

Experimental work published in Anesthesiology examining upper airway function found that ketamine increased activity in the muscles that dilate the upper airway and increased inspiratory duty cycle, effectively decoupling loss of consciousness from airway collapse in a way other agents do not. A separate study measuring upper airway collapsibility found ketamine maintained airway patency with greater compensatory neuromuscular activity than propofol.

Human imaging supports this. An MRI-based study comparing ketamine combined with propofol against propofol alone found the ketamine combination significantly reduced airway narrowing at the soft palate, tongue base and epiglottis. Systematic reviews of ketamine-propofol combinations for procedural sedation consistently report lower rates of airway obstruction, apnea and oxygen desaturation than propofol alone.

Ketamine also tends to preserve protective airway reflexes, which opioids and propofol reliably blunt. Set against opioids in particular, the contrast is stark: opioids depress central respiratory drive, reduce upper airway tone and worsen obstructive events, which is precisely why they are hazardous in this population.

What the guidelines actually say

Consensus guidelines on intravenous ketamine for pain, published in Regional Anesthesia and Pain Medicine in 2018, name obstructive sleep apnea as a population at increased risk for opioid-related respiratory depression and suggest ketamine may be considered specifically as an opioid-sparing option in these patients. The same guidelines are candid that high-quality evidence in the sleep apnea population is lacking.

The Society of Anesthesia and Sleep Medicine guideline published in Anesthesia & Analgesia in 2016 is similarly direct, stating there is a lack of evidence to assess residual effects of ketamine in patients with sleep apnea, while recommending validated screening tools such as STOP-Bang to identify suspected cases. American Society of Anesthesiologists practice guidelines for perioperative management of these patients likewise emphasize preoperative screening, continuation of CPAP where applicable, and enhanced monitoring.

Taken together the guidance is consistent: screen, monitor more closely, and do not assume any agent eliminates risk entirely. Sleep apnea is a risk modifier here, not a closed door.

Sleep apnea and depression feed each other

The other reason we ask is that undiagnosed sleep apnea is a genuinely common cause of symptoms that look exactly like depression. Fragmented sleep produces daytime fatigue, low mood, irritability, poor concentration and diminished motivation. Those overlap almost completely with a depression screen.

If someone has been treated for treatment-resistant depression for years while an untreated airway problem wakes them fifty times a night, ketamine is being asked to compensate for something it cannot fix. We would rather find that out at intake. Occasionally the most useful thing we do at a consultation is send someone for a sleep study, and we treat that as a good outcome rather than a lost one. Our article on ketamine and sleep covers the relationship in more depth, along with ketamine and sleep disorders.

What we do at Music City Ketamine

We screen for sleep apnea at consultation, including diagnosed cases, suspected cases and the classic symptom pattern. If you have been diagnosed, we want to know whether you use CPAP and how consistently, because a well-treated airway and an untreated one are different clinical situations.

Every infusion is run by Marla Peterson, CRNA, whose entire training background is airway management and anesthesia monitoring. This is the population where that matters most. Standard monitoring includes continuous pulse oximetry, cycled blood pressure, heart rate and clinical assessment of breathing and airway. For patients at higher respiratory risk, professional guidance recommends continuous end-tidal carbon dioxide monitoring, and we position patients to keep the airway open rather than fully reclined. The full picture is in what a CRNA is and what Marla does during an infusion.

We also keep doses in the sub-anesthetic range and infuse slowly over roughly 40 minutes. Both matter here: the rare reports of apnea associated with ketamine involve rapid intravenous boluses, not slow low-dose infusions.

Honest expectations

Ketamine is FDA-approved as an anesthetic; its use for depression, anxiety and chronic pain is off-label.

Having sleep apnea does not disqualify you from ketamine therapy at our clinic. Based on both mechanism and the available evidence, ketamine is a relatively favorable choice for patients with airway concerns compared with most sedating alternatives. What it is not is risk-free, and the honest state of the literature is that sleep apnea specific outcome data for ketamine remains limited.

If your apnea is severe and untreated, we may ask you to address that first. That is not us being difficult. It is generally the intervention most likely to improve how you feel, and it makes the infusion safer if you go on to have one. We describe our reasoning in when we decline ketamine for a patient.